Strong investor support demonstrated by raising CHF 90 million through the IPO.
Organizations Involved
GSK
Founders
Marc Gitzinger
Company Description
BioVersys is a Basel-based biotech company focused on combating multidrug-resistant bacteria, developing key products such as BV100 for pneumonia and bloodstream infections, and alpibectir for tuberculosis in collaboration with GSK.